Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia
Zhang, R, Shi, W, Wang, H-F, You, Y, Zhong, Z-D, Li, W-M, Zhang, C, Lu, X, Wang, Y-D, Zheng, P, Fang, J, Hong, M, Wu, Q-L, Xia, L-HLanguage:
english
Journal:
Bone Marrow Transplantation
DOI:
10.1038/bmt.2017.100
Date:
June, 2017
File:
PDF, 591 KB
english, 2017